Management of acne scarring, part II: A comparative review of non-laser-based, minimally invasive approaches

American Journal of Clinical Dermatology

Volumn 13, Issue 5, 2012, Pages 331-340

  Levy, Lauren L ^a   Zeichner, Joshua A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Acne; Azelaic acid; Corticosteroids; Cryotherapy; Hydroquinone; Isotretinoin; Laser therapy; Radiotheapy; Retinoids; Scars

Indexed keywords

AZELAIC ACID; BLEOMYCIN; CORTICOSTEROID; FLUOROURACIL; HYDROQUINONE; ISOTRETINOIN; PLACEBO; PREDNISONE; RETINOID; SILICONE GEL; TRIAMCINOLONE ACETONIDE;

ACNE; ACNE SCARRING; ACNE VULGARIS; BIRTH DEFECT; CHEILITIS; CHEMICAL PEEL; CLINICAL TRIAL; CRYOTHERAPY; DEPRESSION; DERMATITIS; DERMATOLOGICAL PROCEDURE; DISEASE CLASSIFICATION; DRUG DOSE TITRATION; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; KELOID; LASER RESURFACING; MINIMALLY INVASIVE PROCEDURE; PAIN; PATHOGENESIS; PRIORITY JOURNAL; PUNCH EXCISION; PURPURA; REVIEW; SCAR; SCAR FORMATION; SKIN ABRASION; SKIN ATROPHY; SKIN SURGERY; SUICIDAL IDEATION; TELANGIECTASIA; TISSUE AUGMENTATION; ULCERATIVE COLITIS; XEROSIS;

ACNE KELOID; ACNE VULGARIS; ADRENAL CORTEX HORMONES; BIOCOMPATIBLE MATERIALS; CHEMEXFOLIATION; CICATRIX; CICATRIX, HYPERTROPHIC; CRYOSURGERY; CYTOTOXINS; DERMABRASION; DERMATOLOGIC AGENTS; HUMANS; HYPERPIGMENTATION; RETINOIDS;

EID: 84864590076     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11631410-000000000-00000     Document Type: Review

References (136)

1. Stathakis V, Kilkenny M, Marks R. Descriptive epidemiology of acne vulgaris in the community. Australas J Dermatol 1997 Aug; 38 (3): 115-23
2. Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: A community-based study. J Invest Dermatol 2009 Sep; 129 (9): 2136-41
3. Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol 1999 Oct; 41 (4): 577-80
4. Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol 1994 Jul; 19 (4): 303-8
5. Dunn LK, O'Neill JL, Feldman SR. Acne in adolescents: Quality of life, selfesteem, mood, and psychological disorders. Dermatol Online J 2011 Jan 15; 17 (1): 1
6. Halvorsen JA, Stern RS, Dalgard F, et al. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: A population-based study. J Invest ermatol 2011 Feb; 131 (2): 363-70
7. Uhlenhake E, Yentzer BA, Feldman SR. Acne vulgaris and depression: A retrospective examination. J Cosmet Dermatol 2010 Mar; 9 (1): 59-63
8. Bellew S, Thiboutot D, Del Rosso JQ. Pathogenesis of acne vulgaris: What's new, what's interesting and what may be clinically relevant. J Drugs Dermatol 2011 Jun; 10 (6): 582-585.
9. Dessinioti C,Katsambas AD. The role of Propionibacterium acnes in acne pathogenesis: Facts and controversies. Clin Dermatol 2010 Jan-Feb; 28 (1): 2-7
10. Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol 2011 Jan; 3 (1): 41-9
11. Arora MK, Yadav A, Saini V. Role of hormones in acne vulgaris. Clin Biochem 2011 Sep; 44 (13): 1035-40
12. Holland DB, Jeremy AH. The role of inflammation in the pathogenesis of acne and acne scarring. Semin Cutan Med Surg 2005 Jun; 24 (2): 79-83
13. Jeremy AH, Holland DB, Roberts SG, et al. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003 Jul; 121 (1): 20-7
14. Holland DB, Jeremy AH, Roberts SG, et al. Inflammation in acne scarring: A comparison of the responses in lesions from patients prone and not prone to scar. Br J Dermatol 2004 Jan; 150 (1): 72-81
15. Jacob CI, Dover JS, Kaminer MS. Acne scarring: A classification system and review of treatment options. J Am Acad Dermatol 2001 Jul; 45 (1): 109-17
16. KnutsonDD.Ultrastructural observations in acne vulgaris: The normal sebaceous follicle and acne lesions. J Invest Dermatol 1974 Mar; 62 (3): 288-307
17. Fabbrocini G, Annunziata MC, D'Arco V, et al. Acne scars: Pathogenesis, classification and treatment. Dermatol Res Pract 2010; doi:10.1155/ 2010/893080
18. Wolfram D, Tzankov A, Pulzl P, et al. Hypertrophic scars and keloids: A review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 2009 Feb; 35 (2): 171-81
19. Brown JJ, Bayat A. Genetic susceptibility to raised dermal scarring. Br J Dermatol 2009 Jul; 161 (1): 8-18
20. Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease and hypertrophic scarring: Transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 2003 Feb; 111 (2): 535-43; discussion 544-6
21. English RS, Shenefelt PD. Keloids and hypertrophic scars. Dermatol Surg 1999 Aug; 25 (8): 631-8
22. Goodman GJ. Acne and acne scarring: Why should we treat? Med J Aust 1999 Jul 19; 171 (2): 62-3
23. Merritt B, Burkhart CN, Morrell DS. Use of isotretinoin for acne vulgaris. Pediatr Ann 2009 Jun; 38 (6): 311-20
24. Ward A, Brogden RN, Heel RC, et al. Isotretinoin: A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs 1984 Jul; 28 (1): 6-37
25. Dalziel K, Barton S, Marks R. The effects of isotretinoin on follicular and sebaceous gland differentiation. Br J Dermatol 1987 Sep; 117 (3): 317-23
26. Leyden JJ, McGinley KJ. Effect of 13-cis-retinoic acid on sebum production and Propionibacterium acnes in severe nodulocystic acne. Arch Dermatol Res 1982; 272 (3-4): 331-7
27. King K, Jones DH, Daltrey DC, et al. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol 1982 Nov; 107 (5): 583-90
28. Zelickson AS, Strauss JS, Mottaz J. Ultrastructural changes in open comedones following treatment of cystic acne with isotretinoin. Am J Dermatopathol 1985 Jun; 7 (3): 241-4
29. Seguin-Devaux C, Hanriot D, Dailloux M, et al. Retinoic acid amplifies the host immune response to LPS through increased T lymphocytes number and LPS binding protein expression. Mol Cell Endocrinol 2005 Dec 21; 245 (1-2): 67-76
30. Layton AM, KnaggsH, Taylor J, et al. Isotretinoin for acne vulgaris: 10 years later: A safe and successful treatment. Br J Dermatol 1993 Sep; 129 (3): 292-6
31. Layton A. The use of isotretinoin in acne. Dermatoendocrinol 2009 May; 1 (3): 162-9
32. Ben Omar N, Arias JM, Gonzalez-Munoz MT. Extracellular bacterial mineralization within the context of geomicrobiology. Microbiologia 1997 Jun; 13 (2): 161-72
33. Layton AM, Cunliffe WJ. Guidelines for optimal use of isotretinoin in acne. J Am Acad Dermatol 1992 Dec; 27 (6 Pt 2): S2-7
34. Borghi A, Mantovani L, Minghetti S, et al. Acute acne flare following isotretinoin administration: Potential protective role of low starting dose. Dermatology 2009; 218 (2): 178-80
35. Rademaker M. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin. Australas J Dermatol 2010 Nov; 51 (4): 248-53
36. Thakrar BT, Robinson NJ. Isotretinoin and the risk of depression. J Clin Psychiatry 2009 Oct; 70 (10): 1475; author reply 1475-6
37. Hull PR, D'Arcy C. Isotretinoin use and subsequent depression and suicide: Presenting the evidence. Am J Clin Dermatol 2003; 4 (7): 493-505
38. Popescu CM, Popescu R. Isotretinoin therapy and inflammatory bowel disease. Arch Dermatol 2011 Jun; 147 (6): 724-9
39. Reddy D, Siegel CA, Sands BE, et al. Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol 2006 Jul; 101 (7): 1569-73
40. Malvasi A, Tinelli A, Buia A, et al. Possible long-term teratogenic effect of isotretinoin in pregnancy. Eur Rev Med Pharmacol Sci 2009 Sep-Oct; 13 (5): 393-6 41.
41. Maloney ME, Stone SP. Isotretinoin and iPledge: A view of results. JAmAcad Dermatol 2011 Aug; 65 (2): 418-9
42. Layton AM, Seukeran D, Cunliffe WJ. Scarred for life? Dermatology 1997; 195 Suppl. 1: 15-21; discussion 38-40
43. Cunliffe WJ, van de Kerkhof PC, Caputo R, et al. Roaccutane treatment guidelines: Results of an international survey. Dermatology 1997; 194 (4): 351-7
44. Thielitz A, Gollnick H. Topical retinoids in acne vulgaris: Update on efficacy and safety. Am J Clin Dermatol 2008; 9 (6): 369-81
45. Thielitz A, Abdel-Naser MB, Fluhr JW, et al. Topical retinoids in acne: An evidence-based overview. J Dtsch Dermatol Ges 2010 Mar; 8 Suppl. 1: S15-23
46. Jones DA. The potential immunomodulatory effects of topical retinoids. Dermatol Online J 2005 Mar 1; 11 (1): 3
47. Schiltz JR, Lanigan J, Nabial W, et al. Retinoic acid induces cyclic changes in epidermal thickness and dermal collagen and glycosaminoglycan biosynthesis rates. J Invest Dermatol 1986 Nov; 87 (5): 663-7
48. Varani J, Perone P, Griffiths CE, et al. All-trans retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair: Adult skin from sun-protected and sun-exposed sites responds in an identical manner to RA while neonatal foreskin responds differently. J Clin Invest 1994 Nov; 94 (5): 1747-56
49. Harris DW, Buckley CC, Ostlere LS, et al. Topical retinoic acid in the treatment of fine acne scarring. Br J Dermatol 1991 Jul; 125 (1): 81-2 50.
50. Schmidt JB, Binder M, Macheiner W, et al. New treatment of atrophic acne scars by iontophoresis with estriol and tretinoin. Int J Dermatol 1995 Jan; 34 (1): 53-7
51. Schmidt JB, Donath P, Hannes J, et al. Tretinoin-iontophoresis in atrophic acne scars. Int J Dermatol 1999 Feb; 38 (2): 149-53
52. Frank W. Therapeutic dermabrasion: Back to the future. Arch Dermatol 1994 Sep; 130 (9): 1187-9
53. Goodman G. Post acne scarring: A review. J Cosmet Laser Ther 2003 Jun; 5 (2): 77-95
54. Gold MH. Dermabrasion in dermatology. Am J Clin Dermatol 2003; 4 (7): 467-71
55. Aronsson A, Eriksson T, Jacobsson S, et al. Effects of dermabrasion on acne scarring: A review and a study of 25 cases. Acta Derm Venereol 1997 Jan; 77 (1): 39-42
56. Shamban AT, Narurkar VA. Multimodal treatment of acne, acne scars and pigmentation. Dermatol Clin 2009 Oct; 27 (4): 459-71
57. Hirsch RJ, Lewis AB. Treatment of acne scarring. Semin Cutan Med Surg 2001 Sep; 20 (3): 190-8
58. Katz BE, MacFarlane DF. Atypical facial scarring after isotretinoin therapy in a patient with previous dermabrasion. J AmAcad Dermatol 1994 May; 30 (5 Pt 2): 852-3
59. Bagatin E, dos Santos Guadanhim LR, Yarak S, et al. Dermabrasion for acne scars during treatment with oral isotretinoin. Dermatol Surg 2010 Apr; 36 (4): 483-9
60. Mackee GM, Karp FL. The treatment of post-acne scars with phenol. Br J Dermatol 1952 Dec; 64 (12): 456-9
61. Collins PS. Trichloroacetic acid peels revisited. J Dermatol Surg Oncol 1989 Sep; 15 (9): 933-40
62. Grimes PE. Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg 2009 Jun; 28 (2): 77-85
63. Fischer TC, Perosino E, Poli F, et al. Chemical peels in aesthetic dermatology: An update 2009. J Eur Acad Dermatol Venereol 2010 Mar; 24 (3): 281-92
64. Bradley DT, Park SS. Scar revision via resurfacing. Facial Plast Surg 2001 Nov; 17 (4): 253-62
65. Brody HJ. Variations and comparisons in medium-depth chemical peeling. J Dermatol Surg Oncol 1989 Sep; 15 (9): 953-63
66. Lee JB, Chung WG, Kwahck H, et al. Focal treatment of acne scars with trichloroacetic acid: Chemical reconstruction of skin scars method. Dermatol Surg 2002 Nov; 28 (11): 1017-21; discussion 1021
67. Cho SB, Park CO, Chung WG, et al. Histometric and histochemical analysis of the effect of trichloroacetic acid concentration in the chemical reconstruction of skin scars method. ermatol Surg 2006 Oct; 32 (10): 1231-6; discussion 1236
68. Al-Waiz MM, Al-Sharqi AI. Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals. Dermatol Surg 2002 May; 28 (5): 383-7
69. Yug A, Lane JE, Howard MS, et al. Histologic study of depressed acne scars treated with serial high-concentration (95%) trichloroacetic acid. Dermatol Surg 2006 Aug; 32 (8): 985-90; discussion 990
70. Barnett JG, Barnett CR. Treatment of acne scars with liquid silicone injections: 30-year perspective. Dermatol Surg 2005 Nov; 31 (11 Pt 2): 1542-9
71. Beer K. A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella. Dermatol Surg 2007 Dec; 33 Suppl. 2: S159-67
72. Sadick NS, Palmisano L. Case study involving use of injectable poly-L-lactic acid (PLLA) for acne scars. J Dermatolog Treat 2009; 20 (5): 302-7
73. Epstein RE, Spencer JM. Correction of atrophic scars with artefill: An openlabel pilot study. J Drugs Dermatol 2010 Sep; 9 (9): 1062-4
74. Laurent TC, Laurent UB, Fraser JR. The structure and function of hyaluronan: An overview. Immunol Cell Biol 1996 Apr; 74 (2): A1-7
75. Wang F, Garza LA, Kang S, et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol 2007 Feb; 143 (2): 155-63
76. Lee JW, Kim BJ, Kim MN, et al. Treatment of acne scars using subdermal minimal surgery technology. Dermatol Surg 2010 Aug; 36 (8): 1281-7
77. Goodman GJ. Management of post-acne scarring: What are the options for treatment? Am J Clin Dermatol 2000 Jan-Feb; 1 (1): 3-17
78. Redbord KP, Busso M, Hanke CW. Soft-tissue augmentation with hyaluronic acid and calcium hydroxyl apatite fillers. Dermatol Ther 2011 Jan-Feb; 24 (1): 71-81
79. Goldberg DJ, Amin S, Hussain M. Acne scar correction using calcium hydroxylapatite in a carrier-based gel. J Cosmet Laser Ther 2006 Sep; 8 (3): 134-6
80. Perry CM. Poly-L-lactic acid. Am J Clin Dermatol 2004; 5 (5): 361-6; discussion 367-8
81. Valantin MA, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: Results of the open-label study VEGA. IDS 2003 Nov 21; 17 (17): 2471-7
82. Sculptra Aesthetic (injectable polyl-lactic acid) [package insert]. Bridgewater (NJ): Sanofi-aventis U.S. LLC, Dec 2009
83. Sadove R. Injectable poly-L: -lactic acid: A novel sculpting agent for the treatment of dermal fat atrophy after severe acne. Aesthetic Plast Surg 2009 Jan; 33 (1): 113-6
84. Orentreich DS, Orentreich N. Subcutaneous incisionless (subcision) surgery for the correction of depressed scars and wrinkles. Dermatol Surg 1995 Jun; 21 (6): 543-9
85. Alam M, Omura N, Kaminer MS. Subcision for acne scarring: Technique and outcomes in 40 patients.Dermatol Surg 2005Mar; 31 (3): 310-7; discussion 317
86. Sasaki GH. Comparison of results of wire subcision performed alone, with fills, and/or with adjacent surgical procedures. Aesthet Surg J 2008 Nov-Dec; 28 (6): 619-26
87. Balighi K, Robati RM, Moslehi H, et al. Subcision in acne scar with and without subdermal implant: A clinical trial. J Eur Acad Dermatol Venereol 2008 Jun; 22 (6): 707-11
88. Aalami Harandi S, Balighi K, Lajevardi V, et al. Subcision-suction method: A new successful combination therapy in treatment of atrophic acne scars and other depressed scars. J Eur Acad Dermatol Venereol 2011 Jan; 25 (1): 92-9
89. AlGhamdi KM, AlEnazi MM. Versatile punch surgery. J Cutan Med Surg 2011 Mar-Apr; 15 (2): 87-96
90. Grevelink JM, White VR. Concurrent use of laser skin resurfacing and punch excision in the treatment of facial acne scarring. Dermatol Surg 1998 May; 24 (5): 527-30
91. Solotoff SA. Treatment for pitted acne scarring: Postauricular punch grafts followed by dermabrasion. J Dermatol Surg Oncol 1986 Oct; 12 (10): 1079-84
92. Mancuso A, Farber GA. The abraded punch graft for pitted facial scars. J Dermatol Surg Oncol 1991 Jan; 17 (1): 32-4
93. Dzubow LM. Scar revision by punch-graft transplants. J Dermatol Surg Oncol 1985 Dec; 11 (12): 1200-2
94. Whang KK, Lee M. The principle of a three-staged operation in the surgery of acne scars. J Am Acad Dermatol 1999 Jan; 40 (1): 95-7
95. Kang WH, Kim YJ, Pyo WS, et al. Atrophic acne scar treatment using triple combination therapy: Dot peeling, subcision and fractional laser. J Cosmet Laser Ther 2009 Dec; 11 (4): 212-5
96. Jordan R, Cummins C, Burls A. Laser resurfacing of the skin for the improvement of facial acne scarring: A systematic review of the evidence. Br J Dermatol 2000 Mar; 142 (3): 413-23
97. Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg 2002 Aug; 110 (2): 560-71
98. Jalali M, Bayat A. Current use of steroids in management of abnormal raised skin scars. Surgeon 2007 Jun; 5 (3): 175-80
99. Roques C, Teot L. The use of corticosteroids to treat keloids: A review. Int J Low Extrem Wounds 2008 Sep; 7 (3): 137-45
100. Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: Comparison among intralesional corticosteroid, 5- fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol 2002 Sep; 138 (9): 1149-55
101. Gupta S, Sharma VK. Standard guidelines of care: keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol 2011 Jan-Feb; 77 (1): 94-100
102. Chowdri NA, Masarat M, Mattoo A, et al. Keloids and hypertrophic scars: Results with intraoperative and serial postoperative corticosteroid injection therapy. Aust N Z J Surg 1999 Sep; 69 (9): 655-9
103. Verbov J. The place of intralesional steroid therapy in dermatology. Br J Dermatol 1976 Mar; 94 Suppl. 12: 51-8
104. McMichael AJ, Griffiths CE, Talwar HS, et al. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy. Br J Dermatol 1996 Jul; 135 (1): 60-4
105. Sawada Y, Sone K. Hydration and occlusion treatment for hypertrophic scars and keloids. Br J Plast Surg 1992 Nov-Dec; 45 (8): 599-603
106. Puri N, Talwar A. The efficacy of silicone gel for the treatment of hypertrophic scars and keloids. J Cutan Aesthet Surg 2009 Jul; 2 (2): 104-6
107. Borgognoni L. Biological effects of silicone gel sheeting. Wound Repair Regen 2002 Mar-Apr; 10 (2): 118-21
108. Phillips TJ, Gerstein AD, Lordan V. A randomized controlled trial of hydrocolloid dressing in the treatment of hypertrophic scars and keloids. Dermatol Surg 1996 Sep; 22 (9): 775-8
109. Wang XQ, Liu YK, Qing C, et al. A review of the effectiveness of antimitotic drug injections for hypertrophic scars and keloids. Ann Plast Surg 2009 Dec; 63 (6): 688-92
110. Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology 2002; 204 (2): 130-2
111. Saray Y, Gulec AT. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: A preliminary study. Int J Dermatol 2005 Sep; 44 (9): 777-84
112. Huang L, Wong YP, Cai YJ, et al. Low-dose 5-fluorouracil induces cell cycle G2 arrest and apoptosis in keloid fibroblasts. Br J Dermatol 2010 Dec; 163 (6): 1181-5
113. Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol 2004 May; 45 (2): 140-3
114. Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999 Mar; 25 (3): 224-32
115. Hendricks T, Martens MF, Huyben CM, et al. Inhibition of basal and TGF beta-induced fibroblast collagen synthesis by antineoplastic agents: Implications for wound healing. Br J Cancer 1993 Mar; 67 (3): 545-50
116. Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg 2001 Jan; 27 (1): 23-7
117. Aggarwal H, Saxena A, Lubana PS, et al. Treatment of keloids and hypertrophic scars using bleom. J Cosmet Dermatol 2008 Mar; 7 (1): 43-9
118. Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol 1993 Jun; 19 (6): 529-34
119. Rusciani L, Paradisi A, Alfano C, et al. Cryotherapy in the treatment of keloids. J Drugs Dermatol 2006 Jul-Aug; 5 (7): 591-5
120. Burge SM, Bristol M, Millard PR, et al. Pigment changes in human skin after cryotherapy. Cryobiology 1986 Oct; 23 (5): 422-32
121. Zouboulis CC, Blume U, Buttner P, et al. Outcomes of cryosurgery in keloids and hypertrophic scars: A prospective consecutive trial of case series. Arch Dermatol 1993 Sep; 129 (9): 1146-51
122. Yosipovitch G, Widijanti Sugeng M, Goon A, et al. A comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy alone on keloids: A controlled study. J Dermatolog Treat 2001 Jun; 12 (2): 87-90
123. Akita S, Akino K, Yakabe A, et al. Combined surgical excision and radiation therapy for keloid treatment. J Craniofac Surg 2007 Sep; 18 (5): 1164-9
124. Berman B, Bieley HC. Adjunct therapies to surgical management of keloids. Dermatol Surg 1996 Feb; 22 (2): 126-30
125. Quarles FN, Johnson BA, Badreshia S, et al. Acne vulgaris in richly pigmented patients. Dermatol Ther 2007 May-Jun; 20 (3): 122-7
126. Spann CT. Ten tips for treating acne vulgaris in Fitzpatrick skin types IV-VI. J Drugs Dermatol 2011 Jun; 10 (6): 654-7
127. Callender VD. Acne in ethnic skin: Special considerations for therapy. Dermatol Ther 2004; 17 (2): 184-95
128. Barrientos N, Ortiz-Frutos J, Gomez E, et al. Allergic contact dermatitis from a bleaching cream. Am J Contact Dermat 2001 Mar; 12 (1): 33-4
129. Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med 1993 May 20; 328(20): 1438-43
130. Schallreuter KU, Wood JW. A possible mechanism of action for azelaic acid in the human epidermis. Arch Dermatol Res 1990; 282 (3): 168-71
131. Thiboutot D. Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. J Drugs Dermatol 2008 Jan; 7 (1): 13-6
132. Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: A 16-week, baselinecontrolled study. J Drugs Dermatol 2011 Jun; 10 (6): 586-90
133. Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 1999 Jan; 25 (1): 18-22
134. Garg VK, Sinha S, Sarkar R. Glycolic acid peels versus salicylic-mandelic acid peels in active acne vulgaris and post-acne scarring and hyperpigmentation: A comparative study. Dermatol Surg 2009 Jan; 35 (1): 59-65
135. Ho SG, Yeung CK, Chan NP, et al. A retrospective analysis of the management of acne post-inflammatory hyperpigmentation using topical treatment, laser treatment, or combination topical and laser treatments in oriental patients. Lasers Surg Med 2011 Jan; 43 (1): 1-7
136. Kim S, Cho KH. Treatment of facial postinflammatory hyperpigmentation with facial acne in Asian patients using a Q-switched neodymium-doped yttrium aluminum garnet laser. ermatol Surg 2010 Sep; 36 (9): 1374-80